Company / R&D per Share
PALVELLA THERAPEUTICS, INC. R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.66
FY2024
5-year range
$0.12 / $3.66
FY2020-FY2024
Trend
+3003.3%
vs FY2023
Sector context
#56 of 208
Health Care
What the data says
R&D per Share changed +3003% YoY in FY2024, a notable deviation from the 9-year average annual change of +331%.
Based on SEC 10-K filings.
3.66 in FY2024 with a 5-year CAGR of +29.2%.
Improved from $0.73 to $3.66 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +64.0%
- 5-Year CAGR
- +29.2%
- 10-Year CAGR
- -
Sector benchmark
#56 of 208 in Health CareTop 27% of 208This company $3.66 Sector average $12.19
▼
-70.0% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 3003.3% year-over-year.
- Ranks #56 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.66 | +3003.3% |
| FY2023 | $0.12 | -83.9% |
| FY2022 | $0.73 | -11.7% |
| FY2021 | $0.83 | -16.6% |
| FY2020 | $1.00 | -1.9% |
| FY2019 | $1.02 | +105.2% |
| FY2018 | $0.50 | +8.2% |
| FY2017 | $0.46 | -7.5% |
| FY2016 | $0.49 | -16.8% |
| FY2015 | $0.59 | +25.6% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026